Lazard Asset Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-152,558
Closed -$2.38M 1482
2019
Q2
$2.38M Sell
152,558
-23,565
-13% -$421K ﹤0.01% 735
2019
Q1
$3.23M Buy
176,123
+34,500
+24% +$611K 0.01% 662
2018
Q4
$2.36M Buy
141,623
+2,980
+2% +$69.1K ﹤0.01% 630
2018
Q3
$3.91M Sell
138,643
-30,484
-18% -$876K 0.01% 605
2018
Q2
$4.78M Buy
169,127
+16,436
+11% +$489K 0.01% 571
2018
Q1
$4.81M Buy
152,691
+1,945
+1% +$61.4K 0.01% 553
2017
Q4
$4.39M Sell
150,746
-63,071
-29% -$1.72M 0.01% 557
2017
Q3
$6.08M Sell
213,817
-52,715
-20% -$1.36M 0.01% 515
2017
Q2
$6.88M Sell
266,532
-32,502
-11% -$776K 0.01% 496
2017
Q1
$7.18M Sell
299,034
-1,720
-0.6% -$36.1K 0.01% 514
2016
Q4
$5.1M Buy
300,754
+15,285
+5% +$282K 0.01% 525
2016
Q3
$6.87M Buy
285,469
+10,120
+4% +$265K 0.01% 478
2016
Q2
$7.32M Buy
275,349
+16,286
+6% +$477K 0.02% 451
2016
Q1
$7.12M Sell
259,063
-3,275
-1% -$78.9K 0.02% 442
2015
Q4
$8.14M Buy
262,338
+68,943
+36% +$2.09M 0.02% 433
2015
Q3
$5.1M Sell
193,395
-3,958
-2% -$132K 0.01% 485
2015
Q2
$7.12M Sell
197,353
-24,781
-11% -$870K 0.01% 455
2015
Q1
$7.68M Buy
+222,134
New +$8.06M 0.02% 442

Other funds holding CLLS

Lazard Asset Management's CLLS Position: Q3 2019 in Review

Lazard Asset Management sold out of Cellectis (CLLS) in Q3 2019, closing a stake of 152,558 shares — an estimated $2.38M sold.

Lazard Asset Management first reported a position in CLLS in Q1 2015 and held it in 18 quarters. The position peaked at $8.14M in Q4 2015. 64 funds tracked by Wall St. Rank hold CLLS as of Q3 2019.

  • Lazard Asset Management reported no remaining Cellectis position as of Q3 2019 after selling out during the quarter.
  • Lazard Asset Management sold 152,558 Cellectis shares in Q3 2019, an estimated $2.38M.
  • Lazard Asset Management first reported a position in Cellectis in Q1 2015 and held it in 18 quarters.
  • Lazard Asset Management's Cellectis position peaked at $8.14M in Q4 2015.
  • 64 funds tracked by Wall St. Rank held Cellectis as of Q3 2019.

Based on Lazard Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.